Posizioni attive di Erlich Yaniv
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Eleven Therapeutics Ltd.
 Eleven Therapeutics Ltd. Medical/Nursing ServicesHealth Services Eleven Therapeutics Ltd. is an Israeli biotech company that combines artificial intelligence, functional assays, and combinatorial chemistry to develop RNAi therapeutics. The company was founded in 2020 by a group of interdisciplinary scientists and has three collaborative hubs located in undisclosed locations. The company is based in an undisclosed location. Eleven Therapeutics is currently focused on developing siRNA treatments for respiratory diseases using its flagship invention, SCSI-RNA™. This fully programmable molecule is designed to address the delivery, durability, and efficacy challenges of any disease and biological target of interest. The company was founded by Erlich Yaniv, Shaun Ilan, Greg Hannon, and Erlich Yaniv has been the CEO since incorporation. | Amministratore Delegato | 01/01/2017 | - |
| Direttore Tecnico/Scientifico/R&S | - | - | |
| Fondatore | - | - |
Storia della carriera di Erlich Yaniv
Statistiche
Distribuzione geografica
| Israele | 2 |
Posizioni
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Settori
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Eleven Therapeutics Ltd.
Eleven Therapeutics Ltd. Medical/Nursing ServicesHealth Services Eleven Therapeutics Ltd. is an Israeli biotech company that combines artificial intelligence, functional assays, and combinatorial chemistry to develop RNAi therapeutics. The company was founded in 2020 by a group of interdisciplinary scientists and has three collaborative hubs located in undisclosed locations. The company is based in an undisclosed location. Eleven Therapeutics is currently focused on developing siRNA treatments for respiratory diseases using its flagship invention, SCSI-RNA™. This fully programmable molecule is designed to address the delivery, durability, and efficacy challenges of any disease and biological target of interest. The company was founded by Erlich Yaniv, Shaun Ilan, Greg Hannon, and Erlich Yaniv has been the CEO since incorporation. | Health Services |
- Borsa valori
- Insiders
- Erlich Yaniv
- Esperienza
